מיפג'ין

Country: ইস্রায়েল

ভাষা: হিব্রু

সূত্র: Ministry of Health

সক্রিয় উপাদান:

MIFEPRISTONE

থেকে পাওয়া:

A. LAPIDOT PHARMACEUTICALS, LTD

এটিসি কোড:

G03XB01

ফার্মাসিউটিকাল ফর্ম:

טבליה

রচনা:

MIFEPRISTONE 200 MG

প্রশাসন রুট:

פומי

প্রেসক্রিপশন টাইপ:

מרשם נדרש

Manufactured by:

EXELGYNE LABORATORIES, FRANCE

Therapeutic group:

MIFEPRISTONE

Therapeutic area:

MIFEPRISTONE

থেরাপিউটিক ইঙ্গিত:

Medical alternative to uterine suction for termination of intra-utrerine Pregnancy: - up to and no later than 49 days of amenorrhea (seven weeks) - in sequential use with a prostaglandin analogue misoprostol 400 mcg per os administered 36 to 48 hours after Mifegyne intake. Under these conditions the association of mifepristone and prostaglandins leads to a success rate of about 95 per cent of the cases. Preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reason (beyond the first trimester). Softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester.

অনুমোদন তারিখ:

2014-07-31